- Exchanges
- BSE, NSE
- Industry
- Pharmaceuticals
- Issue
- Book building
Sai Parenteral's IPO
₹405.70
+3.49% on listing
Listing-day close · NSE · 2 Apr 2026 · issue price ₹392
Sai Parenteral's’ ₹409 crore IPO was priced at ₹392 a share. It listed on the NSE on 2 Apr 2026 and closed its first day at ₹405.70, up 3.49% on the issue price.
Timeline
- Opens
- Closes
- Allotment
- Refunds
- Shares in demat
- Listing
Issue details
- Issue size
- ₹409 Cr
- Fresh issue
- ₹285 Cr
- Offer for sale
- ₹124 Cr
- Lot size
- 38 shares
- Minimum investment
- ₹14,896
- Face value
- ₹5
- Registrar
- Bigshare Services
Subscription
| Category | Shares offered | Times subscribed |
|---|---|---|
| Total | — | 1.08× |
Overall, from the basis of allotment.
Financials and valuation
- Market cap (post-issue)
- ₹1,732 Cr
- ROE
- 5.13%
- ROCE
- 9.28%
- EBITDA margin
- 18.68%
- PAT margin
- 8.93%
- Promoter holding
- 61.23% → 51.16%
Financials as of 30 Sep 2025, from the offer documents.
Listing
- Listing date
- 2 Apr 2026
- Issue price
- ₹392
- Open
- ₹400.00
- High
- ₹416.00
- Low
- ₹400.00
- Close
- ₹405.70
Listing day on the NSE. The close was +3.49% on the issue price.
FAQs
When did the Sai Parenteral's IPO open and close?
It opened on 24 Mar 2026 and closed on 27 Mar 2026.
What was the Sai Parenteral's IPO price?
The price band was ₹372–392 a share. The final issue price was ₹392.
What is the lot size and minimum investment?
One lot is 38 shares, ₹14,896 at ₹392 a share. Retail investors apply in whole lots.
How much did Sai Parenteral's raise?
₹409 crore: ₹285 crore of new shares and ₹124 crore offered by existing shareholders.
How many times was the Sai Parenteral's IPO subscribed?
1.08 times overall.
How did Sai Parenteral's list?
It listed on the NSE on 2 Apr 2026 at ₹400.00 and closed the day at ₹405.70, up 3.49% on the ₹392 issue price.
Who is the registrar of the Sai Parenteral's IPO?
Bigshare Services handles the allotment, refunds and credit of shares.
For information only. Not investment advice or a research report.
Full disclaimerSee how an IPO fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app